Advanced Science,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 27, 2024
Isoniazid
and
rifampicin
co-therapy
are
the
main
causes
of
anti-tuberculosis
drug-induced
liver
injury
(ATB-DILI)
acute
failure,
seriously
threatening
human
health.
However,
its
pathophysiology
is
not
fully
elucidated.
Growing
evidences
have
shown
that
fibroblast
growth
factors
(FGFs)
play
a
critical
role
in
diverse
aspects
pathophysiology.
The
aim
this
study
to
investigate
FGFs
pathogenesis
isoniazid
(INH)
(RIF)-induced
injury.
Through
systematic
screening,
finds
hepatic
FGF1
expression
significantly
downregulated
both
mouse
model
patients
challenged
with
INH
RIF.
Hepatocyte-specific
Fgf1
deficiency
exacerbates
RIF-induced
resulted
from
elevated
bile
acids
(BAs)
synthases
aberrant
BAs
accumulation.
Conversely,
pharmacological
administration
non-mitogenic
analog
-
FGF1ΔHBS
alleviated
via
restoring
homeostasis.
Mechanically,
repressed
hepatocyte
nuclear
factor
4α
(Hnf4α)
transcription
activating
FGF
receptor
4
(FGFR4)-ERK1/2
signaling
pathway,
thus
reducing
synthase.
findings
demonstrate
functions
as
negative
regulator
biosynthesis
protect
against
normalizing
homeostasis,
providing
novel
mechanistic
insights
into
ATB-DILI
potential
therapeutic
strategies
for
treatment
ATB-DILI.
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: Jan. 4, 2025
Abstract
Recent
studies
suggest
the
role
of
gut
microbes
in
bile
acid
metabolism
development
and
progression
colorectal
cancer.
However,
surveys
association
between
fecal
concentrations
cancer
(CRC)
have
been
inconsistent.
We
searched
online
to
identify
relevant
cross-sectional
case-control
published
major
English
language
databases
(Medline,
Embase,
Web
Science,
AMED,
CINAHL)
up
January
1,
2024.
selected
according
inclusion
exclusion
criteria
extracted
data
from
them.
RevMan
5.3
was
used
perform
meta-analyses.
In
CRC
risk
meta-analysis,
effect
size
CA
(cholic
acid),
CDCA
(chenodeoxycholic
DCA
(deoxycholic
UDCA
(ursodeoxycholic
acid)
were
significantly
higher
(CA:
standardized
mean
difference
[SMD]
=
0.41,
95%
confidence
interval
[CI]:
0.5–0.76,
P
0.02;
CDCA:
SMD
0.35,
CI:
0.09–0.62,
0.009;
DCA:
0.33,95%
0.03–0.64,
0.03;
UDCA:
0.46,
0.14–0.78,
0.005),
combined
high-risk
than
low-risk
group
(SMD
0.36,
0.21–0.51,
<
0.00001).
incidence
sizes
0.42,
0.04–0.80,
0.61,
0.26–0.96,
0.00079),
their
also
compared
0.39,
0.09–0.68,
0.01).
Only
one
study
suggested
a
concentration
CDCA,
DCA,
stool
group.
These
findings
indicate
that
may
be
associated
with
risk/incidence
CRC.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: March 17, 2025
Antimicrobial
resistance
(AMR)
has
become
a
major
and
escalating
global
health
threat,
undermining
the
effectiveness
of
current
antibiotic
antimicrobial
therapies.
The
rise
multidrug-resistant
bacteria
led
to
increasingly
difficult-to-treat
infections,
resulting
in
higher
morbidity,
mortality,
healthcare
costs.
Tackling
this
crisis
requires
development
novel
agents,
optimization
therapeutic
strategies,
initiatives
infection
surveillance
control.
Recent
studies
highlight
crucial
role
human
gut
microbiota
defending
against
AMR
pathogens.
A
balanced
protects
body
through
mechanisms
such
as
colonization
resistance,
positioning
it
key
ally
fight
AMR.
In
contrast,
dysbiosis
disrupts
defense,
thereby
facilitating
persistence,
colonization,
dissemination
resistant
This
review
will
explore
how
influence
drug-resistant
bacterial
its
involvement
various
types
AMR-related
potential
for
microbiota-targeted
therapies,
fecal
transplantation,
prebiotics,
probiotics,
phage
therapy.
Elucidating
interactions
between
pathogens
provide
critical
insights
developing
strategies
prevent
treat
infections.
While
previous
reviews
have
focused
on
general
impact
health,
specifically
look
at
latest
research
evolution
spread
AMR,
highlighting
strategies.
European journal of medical research,
Journal Year:
2025,
Volume and Issue:
30(1)
Published: April 7, 2025
Inflammatory
bowel
disease
(IBD)
includes
chronic
inflammatory
conditions,
such
as
Crohn's
and
ulcerative
colitis,
characterized
by
impaired
function
of
the
intestinal
mucosal
epithelial
barrier.
In
recent
years,
ferroptosis,
a
novel
form
cell
death,
has
been
confirmed
to
be
involved
in
pathological
process
IBD
is
related
various
changes,
oxidative
stress
inflammation.
Recent
studies
have
further
revealed
complex
interactions
between
microbiome
indicating
that
ferroptosis
an
important
target
for
regulation
gut
microbiota
its
metabolites.
This
article
reviews
significant
roles
microbial
metabolites,
short-chain
fatty
acids,
tryptophan,
bile
IBD.
These
metabolites
participate
influencing
microenvironment,
modulating
immune
responses,
altering
levels,
thereby
exerting
impact
on
development
Treatments
based
are
gradually
becoming
research
hotspot.
Finally,
we
discuss
potential
current
therapeutic
approaches,
including
antibiotics,
probiotics,
prebiotics,
fecal
transplantation,
microbiota,
affecting
improving
symptoms.
With
deeper
understanding
interaction
mechanisms
it
expected
more
precise
effective
treatment
strategies
will
developed
future.
Nature Communications,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: April 11, 2025
Conjugated
bile
acids
(BAs)
are
multi-functional
detergents
in
the
gastrointestinal
(GI)
tract
produced
by
liver
enzyme
acid-CoA:amino
acid
N-acyltransferase
(BAAT)
and
microbiome
from
acyltransferase
activity
of
salt
hydrolase
(BSH).
Humans
with
inflammatory
bowel
disease
(IBD)
have
an
enrichment
both
host
microbially
conjugated
BAs
(MCBAs),
but
their
impacts
on
GI
inflammation
not
well
understood.
We
investigated
role
host-conjugated
a
mouse
model
colitis
using
BAAT
knockout
background.
Baat-/-
KO
mice
severe
phenotypes
that
were
rescued
supplementation
taurocholate
(TCA).
Gene
expression
histology
showed
this
rescue
was
due
to
improved
epithelial
barrier
integrity
goblet
cell
function.
However,
metabolomics
also
TCA
resulted
extensive
metabolism
secondary
BAs.
therefore
BSH
diverse
gut
bacteria
panel
found
broad
hydrolytic
capacity
depending
bacterium
amino
conjugate.
The
complexity
microbial
BA
hydrolysis
led
exploration
bsh
genes
metagenomic
data
human
IBD
patients.
Certain
sequences
enriched
people
Crohn's
particularly
Ruminococcus
gnavus.
This
study
shows
may
provide
benefits
those
IBD,
is
dictated
delicate
balance
between
conjugation/deconjugation
based
present.
Gut Microbes,
Journal Year:
2025,
Volume and Issue:
17(1)
Published: April 11, 2025
Inflammatory
bowel
disease
(IBD),
including
Crohn's
and
ulcerative
colitis,
is
considered
significant
global
health
concerns
worldwide.
Many
studies
have
demonstrated
that
environmental
dietary
factors
influence
the
gut
microbiota,
which
in
turn
orchestrates
host
immune
responses.
These
interactions
are
also
involved
complex
metabolic
processes
contribute
to
pathogenesis
of
IBD.
Furthermore,
recent
genomics
metabolomics
unveiled
intricate
relationship
between
microbial
influencers
epigenetics.
The
dynamics
microbiota
its
metabolites
intricately
align
with
DNA
methylation,
histone
lactylation,
glycosylation,
non-coding
RNAs,
key
players
Here,
we
summarize
discuss
interplay
among
epigenetics,
factors,
their
impact
on
highlight
importance
multi-omics
technologies
dissecting
host-microbe
IBD,
potentially
offering
a
framework
for
developing
effective
treatment
strategies.
Frontiers in Microbiology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 29, 2025
Purpose
The
purpose
of
this
study
is
to
analyze
the
current
research
status
and
explore
relationship
between
metabolites
inflammatory
bowel
disease
(IBD),
providing
insights
for
future
research.
Methods
In
study,
we
retrieved
publications
on
IBD
from
Web
Science
Core
Collection
(WOSCC),
covering
period
1994
2024.
We
conducted
descriptive
visual
analyses
topics,
journals,
countries/regions,
institutions,
authors,
citation
counts
these
publications.
Results
From
January
June
2024,
a
total
509
relevant
were
WOSCC,
with
number
steadily
increasing
each
year.
These
articles
published
in
222
top
three
most
productive
journals
being
diseases
(36
publications),
Alimentary
Pharmacology
&
Therapeutics
(16
Digestive
Diseases
Sciences
(13
publications).
leading
countries
publication
output
China
(154
publications,
30.3%),
USA
(101
19.8%),
UK
(32
6.3%),
3,175,
7,439,
1,444,
respectively.
recent
trending
keywords
field
include
“gut
microbiota,”
“inflammation,”
“pathogenesis.”
Conclusion
Recent
(IBD)
has
grown
significantly,
deepening
our
understanding
their
connection.
Further
exploration
could
not
only
enhance
quality
life
patients
but
also
offer
new
into
potential
cures
disease.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(9), P. 4240 - 4240
Published: April 29, 2025
Bile
acids
and
their
corresponding
intestinal
epithelial
receptors,
the
farnesoid
X
receptor
(FXR),
G
protein-coupled
bile
acid
(TGR5),
play
crucial
roles
in
physiological
pathological
processes
of
cells.
These
receptors
are
involved
regulation
absorption,
signal
transduction,
cellular
proliferation
repair,
senescence,
energy
metabolism,
modulation
gut
microbiota.
A
comprehensive
literature
search
was
conducted
using
PubMed,
employing
keywords
such
as
acid,
receptor,
FXR
(nr1h4),
TGR5
(gpbar1),
cells,
proliferation,
differentiation,
microbiota,
inflammatory
bowel
disease
(IBD),
colorectal
cancer
(CRC),
irritable
syndrome
(IBS),
with
a
focus
on
publications
available
English.
This
review
examines
diverse
effects
signaling
pathways
metabolism
Additionally,
it
explores
interactions
between
acids,
well
implications
these
for
host
health,
particularly
relation
to
prevalent
diseases.
Finally,
highlights
importance
developing
highly
specific
ligands
context
metabolic
disorders.